Abstract

Ondansetron Hydrochloride 0.8mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2007 - Diabetes

Page(s): 158

Download in electronic PDF format for $75

Abstract

A formulation for preparing Ondansetron Hydrochloride 0.8mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2007 Pg. 158	Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 339	Ondansetron Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 60	Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 126-129	Basics of Compounding for the Treatment of Warts Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 255-263	Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions Author(s): de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
May/Jun 2006 Pg. 222	Granisetron 0.05-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 2005 Pg. 339-346	Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Author(s): Mishkan Emilyn S
May/Jun 2007 Pg. 212-218	Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Author(s): McNulty Jack P
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr